Getting Revlimid (Lenalidomide) Covered by Cigna in Illinois: Prior Authorization Forms, Appeals Process & Timeline

Answer Box: Quick Path to Approval

Revlimid (lenalidomide) requires prior authorization from Cigna, including REMS certification and diagnosis-specific clinical criteria. In Illinois, if denied, you have 180 days for internal appeals and 30 days after final denial for external review through the Illinois Department of Insurance. First step today: Verify your prescriber is REMS-certified and check your formulary status via Cigna's member portal or 1-800 number on your card.

Table of Contents

  1. Coverage Requirements at a Glance
  2. Step-by-Step: Fastest Path to Approval
  3. Medical Necessity Criteria
  4. Common Denial Reasons & Solutions
  5. Appeals Process in Illinois
  6. Cost-Saving Options
  7. FAQ
  8. When to Escalate

Coverage Requirements at a Glance

Requirement What It Means Where to Find It Source
Prior Authorization Physician must submit clinical documentation proving medical necessity Cigna PA forms portal Cigna Policy
REMS Certification Prescriber and pharmacy must be registered in Lenalidomide REMS program Call Lenalidomide REMS directly FDA Requirement
Formulary Status Revlimid in Tier 2-5 with restrictions; generic lenalidomide preferred Cigna member portal or drug list 2026 Formulary Changes
Step Therapy Must try ≥1 prior regimen for most indications PA submission form Cigna Oncology Policy
Quantity Limits Typically 21-28 day cycles with dosing restrictions Plan-specific drug list Formulary Documents

Step-by-Step: Fastest Path to Approval

1. Verify REMS Certification (Day 1)

Who: Clinic staff
Action: Confirm prescriber and intended pharmacy are REMS-certified
Timeline: Same day
Link: Contact Lenalidomide REMS program directly

2. Check Formulary Status (Day 1)

Who: Patient or clinic
Action: Log into Cigna member portal or call member services
Timeline: 10-15 minutes
Link: Use number on insurance card

3. Gather Clinical Documentation (Days 1-2)

Who: Clinic staff
Action: Collect diagnosis codes, prior therapy records, lab results, pathology reports
Timeline: 1-2 business days
Documentation needed: ICD-10 codes, treatment history with dates/outcomes, recent CBC/CMP

4. Submit Prior Authorization (Day 3)

Who: Prescriber
Action: Complete Cigna PA form with clinical justification
Timeline: Submit within 72 hours of gathering docs
Portal: Cigna PA submission system

5. Request Expedited Review if Urgent (Day 3)

Who: Prescriber
Action: Call Cigna to request 24-hour expedited review
Timeline: Decision within 24 hours for urgent cases
Standard timeline: Up to 72 hours for non-urgent

6. Follow Up on Decision (Days 4-7)

Who: Patient or clinic
Action: Check PA status via portal or phone
Timeline: Standard decisions within 72 hours

7. Prepare Appeal if Denied (Day of denial notification)

Who: Patient with clinic support
Action: Begin gathering additional evidence for internal appeal
Timeline: Must file within 180 days in Illinois

Medical Necessity Criteria

Based on Cigna's oncology policy, your PA submission must address these specific criteria:

Multiple Myeloma

  • Patient ≥18 years old
  • Used with dexamethasone for newly diagnosed or relapsed disease
  • Documentation of prior therapy failure with specific dates, doses, adverse events, and progression evidence
  • Must align with NCCN Category 2A recommendations

Follicular Lymphoma (Previously Treated)

  • Used with rituximab OR Gazyva
  • OR documentation of ≥1 prior regimen failure (e.g., bendamustine + Gazyva)

Mantle Cell Lymphoma

  • Patient ≥18 years old
  • Used with rituximab OR ≥1 prior regimen documented
  • Examples of qualifying prior regimens: CHOP-R, bendamustine + rituximab
Clinician Corner: Your medical necessity letter should include: (1) specific diagnosis with ICD-10 code, (2) detailed prior treatment history with dates and outcomes, (3) current clinical status with recent labs/imaging, (4) proposed dosing based on renal function/BSA, and (5) combination therapy plan. Reference the specific Cigna criteria above and cite NCCN guidelines where applicable.

Common Denial Reasons & Solutions

Denial Reason How to Overturn Required Documentation
REMS non-compliance Ensure certification complete before resubmission REMS confirmation numbers
Inadequate prior therapy documentation Submit detailed treatment history with outcomes Clinic notes, lab results, imaging showing progression
Off-label use without evidence Provide peer-reviewed studies and guideline support PubMed citations, NCCN references
Generic preference Document intolerance or bioavailability issues with generic Clinical notes showing specific adverse events
Quantity limits exceeded Justify dosing based on patient weight, renal function Current labs, dosing calculations

Appeals Process in Illinois

Illinois provides strong patient protections with specific timelines that differ from other states.

Internal Appeals (First Level)

  • Timeline to file: 180 days from denial notice
  • Cigna decision timeline: 15 business days for pre-service requests
  • Expedited timeline: 24 hours for urgent cases
  • How to file: Cigna member portal or written appeal to address on denial letter

External Review (After Internal Appeal Denial)

  • Critical deadline: 30 days from final internal denial (shorter than many states)
  • Process: Illinois Department of Insurance assigns Independent Review Organization (IRO)
  • Timeline: IRO decision within 5 business days after receiving records
  • Cost: Free to consumers; insurers pay review costs
  • Contact: Illinois Department of Insurance at 877-527-9431
Important: Illinois' 30-day external review deadline is stricter than the 4-month window in many states. Don't delay if your internal appeal is denied.

Illinois-Specific Resources

  • Office of Consumer Health Insurance (OCHI): 877-527-9431 for appeal assistance
  • Illinois Attorney General Health Care Helpline: 877-305-5145 for informal intervention
  • External review forms: Available at Illinois Department of Insurance website

When navigating complex prior authorization and appeals processes, Counterforce Health helps patients and clinicians turn insurance denials into targeted, evidence-backed appeals. Their platform analyzes denial letters and plan policies to draft point-by-point rebuttals aligned with each payer's specific requirements, potentially saving weeks of back-and-forth during critical treatment decisions.

Cost-Saving Options

Manufacturer Support

  • Bristol Myers Squibb Patient Assistance: Income-based free drug program
  • Revlimid Copay Card: May reduce out-of-pocket costs for commercially insured patients
  • Eligibility: Verify income limits and insurance type restrictions

Foundation Grants

  • Patient Access Network (PAN) Foundation: Blood cancer fund
  • Leukemia & Lymphoma Society: Patient financial aid program
  • Good Days: Chronic disease assistance

State Programs

  • Illinois Prescription Drug Discount Program: Available to all Illinois residents
  • Contact: Illinois Department of Public Health for current programs

Frequently Asked Questions

How long does Cigna prior authorization take for Revlimid in Illinois? Standard PA decisions take up to 72 hours. Expedited reviews for urgent cases are completed within 24 hours. Illinois doesn't alter these federal timelines.

What if Revlimid is non-formulary on my Cigna plan? You can request a formulary exception by documenting why preferred alternatives aren't appropriate. This requires additional clinical justification beyond standard PA criteria.

Can I get an expedited appeal in Illinois? Yes, for both internal appeals (24-hour decision) and external reviews (24-72 hours for urgent cases). Your prescriber must support the urgency request.

Does step therapy apply if I've tried treatments outside Illinois? Yes, prior therapy from any location counts toward step therapy requirements. Ensure your new Illinois provider has complete treatment records.

What happens if I miss the 30-day external review deadline? Illinois' deadline is firm, but you may have other options like filing a complaint with the Illinois Department of Insurance or seeking legal counsel for exceptional circumstances.

How do I find REMS-certified pharmacies in Illinois? Contact the Lenalidomide REMS program directly for a current list of certified pharmacies in your area. Not all pharmacies can dispense Revlimid.

Can I appeal to Medicare if I have Cigna Medicare Advantage? For Medicare Advantage plans, you follow Cigna's process first, then can appeal to Medicare if denied. The timelines and forms differ from commercial insurance.

What if my oncologist won't help with the appeal? You have the right to file appeals yourself. Counterforce Health can help patients and clinicians prepare comprehensive appeals with proper clinical evidence and payer-specific formatting.

When to Escalate

File a State Complaint

Contact the Illinois Department of Insurance if:

  • Cigna misses appeal deadlines
  • You believe the denial violates Illinois insurance law
  • The external review process isn't followed properly

Contact: 877-527-9431 or file online at insurance.illinois.gov

Consider legal advice if:

  • Multiple appeals have been denied despite meeting medical criteria
  • You suspect bad faith denial practices
  • Emergency treatment is being delayed due to coverage disputes

Federal Resources

  • Medicare beneficiaries: Contact 1-800-MEDICARE for Medicare Advantage plan issues
  • ACA marketplace plans: Healthcare.gov consumer assistance

Sources & Further Reading


Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Insurance coverage decisions depend on individual plan terms, medical circumstances, and current policies. Always consult with your healthcare provider and insurance company for guidance specific to your situation. For personalized assistance with insurance appeals and prior authorizations, consider consulting with patient advocacy services or legal professionals familiar with Illinois insurance law.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.